| Financial Year |
March 31 2023 |
| Monetary Funds |
512,753,601.61 |
| Held-for-trading Financial Assets |
85,453,820.93 |
| Notes Receivable |
-- |
| Accounts Receivable |
288,912,939.65 |
| Advances to Suppliers |
19,424,008.84 |
| Other Receivables |
18,331,841.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
366,130,454.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,364,445.08 |
| Total Current Assets |
1,403,863,582.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
262,231,994.08 |
| Investment Properties |
66,883,522.81 |
| Fixed Assetes |
571,558,806.04 |
| Under-construction Projects |
8,708,135.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
96,488,476.10 |
| R&D expenses |
-- |
| Goodwill |
48,986,961.22 |
| Long-Term Deferred and Prepaid Expenses |
7,202,770.67 |
| Deferred Income Tax Assets |
91,863,590.14 |
| Other Non-Current Assets |
6,741,521.99 |
| Sub-Total of Non-Current Assets |
1,281,918,519.44 |
| Total Assets |
2,685,782,102.25 |
| Short-Term Loans |
42,245,353.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
256,712,727.34 |
| Accounts Payable |
160,535,341.68 |
| Accounts Received In Advance |
4,080,076.89 |
| Employee Compensation Payable |
5,624,012.56 |
| Taxes Payable |
6,740,557.97 |
| Interest Payable |
-- |
| Dividend Payable |
5,019,843.42 |
| Other payables |
33,104,493.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,169,813.74 |
| Other Current Liabilities |
691,775.92 |
| Sub-Total of Current Liabilities |
552,802,332.67 |
| Long-term Loans |
49,900,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,871,798.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
95,181,591.31 |
| Total Liabilities |
647,983,923.98 |
| Paid-In Capital(Or Share Stock) |
1,059,988,922.00 |
| Capital Surplus |
494,858,386.34 |
| Surplus Reserve |
120,220,833.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
194,608,138.52 |
| Minority Stockholder's Interest |
163,750,244.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,874,047,933.65 |
| Owner's Equity（Stockholder's Equity） |
2,037,798,178.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,685,782,102.25 |
